CBL and myeloproliferative neoplasm: Not surprisingly, CBL mutations have been reported in 10% of patients with MDS/myeloproliferative neoplasm (MPN) overlap syndrome and these patients display clinical features such as splenomegaly, monocytosis, and anemia [38,39].